135 related articles for article (PubMed ID: 17192106)
1. Total synthesis of herbimycin A.
Canova S; Bellosta V; Bigot A; Mailliet P; Mignani S; Cossy J
Org Lett; 2007 Jan; 9(1):145-8. PubMed ID: 17192106
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis of herbimycin A.
Carter KD; Panek JS
Org Lett; 2004 Jan; 6(1):55-7. PubMed ID: 14703349
[TBL] [Abstract][Full Text] [Related]
3. Synthetic ansamycins prepared by a ring-expanding Claisen rearrangement. Synthesis and biological evaluation of ring and conformational analogues of the Hsp90 molecular chaperone inhibitor geldanamycin.
McErlean CS; Proisy N; Davis CJ; Boland NA; Sharp SY; Boxall K; Slawin AM; Workman P; Moody CJ
Org Biomol Chem; 2007 Feb; 5(3):531-46. PubMed ID: 17252137
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 90: inhibitors in clinical trials.
Biamonte MA; Van de Water R; Arndt JW; Scannevin RH; Perret D; Lee WC
J Med Chem; 2010 Jan; 53(1):3-17. PubMed ID: 20055425
[No Abstract] [Full Text] [Related]
5. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
Ge J; Normant E; Porter JR; Ali JA; Dembski MS; Gao Y; Georges AT; Grenier L; Pak RH; Patterson J; Sydor JR; Tibbitts TT; Tong JK; Adams J; Palombella VJ
J Med Chem; 2006 Jul; 49(15):4606-15. PubMed ID: 16854066
[TBL] [Abstract][Full Text] [Related]
6. Total synthesis of the Hsp90 inhibitor geldanamycin.
Qin HL; Panek JS
Org Lett; 2008 Jun; 10(12):2477-9. PubMed ID: 18489177
[TBL] [Abstract][Full Text] [Related]
7. Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy.
Franke J; Eichner S; Zeilinger C; Kirschning A
Nat Prod Rep; 2013 Oct; 30(10):1299-323. PubMed ID: 23934201
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
[TBL] [Abstract][Full Text] [Related]
9. Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors.
Zhang MQ; Gaisser S; Nur-E-Alam M; Sheehan LS; Vousden WA; Gaitatzis N; Peck G; Coates NJ; Moss SJ; Radzom M; Foster TA; Sheridan RM; Gregory MA; Roe SM; Prodromou C; Pearl L; Boyd SM; Wilkinson B; Martin CJ
J Med Chem; 2008 Sep; 51(18):5494-7. PubMed ID: 18800759
[TBL] [Abstract][Full Text] [Related]
10. Convergent synthesis and discovery of a natural product-inspired paralog-selective Hsp90 inhibitor.
Jeso V; Cherry L; Macklin TK; Pan SC; LoGrasso PV; Micalizio GC
Org Lett; 2011 Oct; 13(19):5108-11. PubMed ID: 21866939
[TBL] [Abstract][Full Text] [Related]
11. Rational design and synthesis of ansa-adenosines as potential antitumor agents.
Muranaka K; Ichikawa S; Matsuda A
Nucleic Acids Symp Ser (Oxf); 2009; (53):5-6. PubMed ID: 19749232
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE
J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a red-shifted fluorescence polarization probe for Hsp90.
Moulick K; Clement CC; Aguirre J; Kim J; Kang Y; Felts S; Chiosis G
Bioorg Med Chem Lett; 2006 Sep; 16(17):4515-8. PubMed ID: 16797988
[TBL] [Abstract][Full Text] [Related]
14. Total synthesis of macbecin I.
Belardi JK; Micalizio GC
Angew Chem Int Ed Engl; 2008; 47(21):4005-8. PubMed ID: 18404757
[No Abstract] [Full Text] [Related]
15. Molecular characterization of macbecin as an Hsp90 inhibitor.
Martin CJ; Gaisser S; Challis IR; Carletti I; Wilkinson B; Gregory M; Prodromou C; Roe SM; Pearl LH; Boyd SM; Zhang MQ
J Med Chem; 2008 May; 51(9):2853-7. PubMed ID: 18357975
[TBL] [Abstract][Full Text] [Related]
16. Studies on the syntheses of benzoquinone ansamycin antibiotics. Syntheses of the C5-C15 subunits of macbecin I, geldanamycin, and herbimycin A.
Belardi JK; Micalizio GC
Org Lett; 2006 May; 8(11):2409-12. PubMed ID: 16706538
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
Zapf CW; Bloom JD; McBean JL; Dushin RG; Golas JM; Liu H; Lucas J; Boschelli F; Vogan E; Levin JI
Bioorg Med Chem Lett; 2011 Jun; 21(12):3627-31. PubMed ID: 21605975
[TBL] [Abstract][Full Text] [Related]
18. Total synthesis of herbimycin A.
Yan R; Bian C; Yu X
Org Lett; 2014 Jun; 16(12):3280-3. PubMed ID: 24911938
[TBL] [Abstract][Full Text] [Related]
19. Hsp90 inhibitors: clinical development and future opportunities in oncology therapy.
Gao Z; Garcia-Echeverria C; Jensen MR
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):193-202. PubMed ID: 20205053
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of the heat-shock protein 90 inhibitor geldanamycin: new insight into the formation of the benzoquinone moiety.
Lee D; Lee K; Cai XF; Dat NT; Boovanahalli SK; Lee M; Shin JC; Kim W; Jeong JK; Lee JS; Lee CH; Lee JH; Hong YS; Lee JJ
Chembiochem; 2006 Feb; 7(2):246-8. PubMed ID: 16381049
[No Abstract] [Full Text] [Related]
[Next] [New Search]